Sort by
Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Adult Acute Lymphoblastic Leukemia
100%
Acute Myeloid Leukemia
80%
Hematopoietic Cell Transplantation
40%
Leukemia Patients
40%
Treatment-related Mortality
40%
Graft-versus-host Disease (GvHD)
20%
Risk Stratification
20%
Improved Outcomes
20%
Patient Demographics
20%
Induction Therapy
20%
Disease Biology
20%
Mortality Rate
20%
Treatment Outcome
20%
Relapse Risk
20%
Graft-versus-leukemia Effect
20%
Post-remission Therapy
20%
Leukemia Risk
20%
Complete Remission
20%
Alternative Donor
20%
Intermediate Risk
20%
Minimal Residual Disease
20%
Autograft
20%
Scientific Advances
20%
Relapse Rate
20%
Leading Causes of Death
20%
Donor-recipient Matching
20%
Therapeutic Modalities
20%
Favorable Risk
20%
Histocompatibility
20%
Treatment Intensification
20%
Transplant Experiment
20%
Risk Issues
20%
Clinical Progress
20%
Medicine and Dentistry
Hematopoietic Cell
100%
Acute Myeloid Leukemia
100%
Cell Transplantation
100%
Clinician
14%
Patient Population
14%
Risk Stratification
14%
Chronic Graft Versus Host Disease
14%
Graft Versus Leukemia Effect
14%
Autograft
14%
Mortality Rate
14%
Alternative Donor
14%
Recurrence Risk
14%
Therapeutic Modality
14%
Minimal Residual Disease
14%
Histocompatibility
14%
Diseases
14%
Treatment Outcome
14%